Erythropoiesis-stimulating agents (ESAs)
Title
Date Published
Shortened red blood cell lifespan is related to the dose of erythropoiesis-stimulating agents requirement in patients on hemodialysis.
December 1, 2012
Treatment of anemia with erythropoietin-stimulating agents in kidney transplant recipients and chronic kidney disease-another drawback of immunosuppression?
December 1, 2012
Occurrence and determinants of poor response to short-term pre-operative erythropoietin treatment.
November 27, 2012
Administration of recombinant erythropoietin alone does not improve the phenotype in iron refractory iron deficiency anemia patients.
November 20, 2012
Rechallenge with intravenous recombinant human erythropoietin can be successful following the treatment of anti-recombinant erythropoietin associated pure red cell aplasia.
October 30, 2012
Dose of erythropoiesis-stimulating agents and adverse outcomes in CKD: a metaregression analysis.
August 22, 2012
Safety of preoperative erythropoietin in surgical calvarial remodeling: an 8-year retrospective review and analysis.
August 1, 2012
Effects of preoperative intravenous erythropoietin plus iron on outcome in anemic patients after cardiac valve replacement.
July 7, 2012
Effects of Preoperative Intravenous Erythropoietin Plus Iron on Outcome in Anemic Patients After Cardiac Valve Replacement.
July 6, 2012
Eltrombopag and improved hematopoiesis in refractory aplastic anemia.
July 5, 2012
The Use of Epoetin-α in Revision Knee Arthroplasty.
July 1, 2012
Impact of erythropoiesis-stimulating agents on red blood cell transfusion in Korea.
June 23, 2012
The Use of Preoperative Epoetin-α in Revision Hip Arthroplasty.
May 11, 2012
Historical clinical and economic consequences of anemia management in patients with end-stage renal disease on dialysis using erythropoietin stimulating agents versus routine blood transfusions: a retrospective cost-effectiveness analysis.
December 16, 2011
Erythropoiesis-stimulating agents are not associated with increased risk of thrombosis in patients with myelodysplastic syndromes.
November 18, 2011
Effect of single recombinant human erythropoietin injection on transfusion requirements in preoperatively anemic patients undergoing valvular heart surgery.
November 1, 2011
Recombinant human erythropoeitin: efficacy and safety considerations for maximizing blood conservation in cardiac surgery.
November 1, 2011
Association of mean weekly epoetin alfa dose with mortality risk in a retrospective cohort study of Medicare hemodialysis patients.
August 9, 2011
Treatment patterns and outcomes in management of solid cancer patients suffering from anemia in Penang hospital.
June 30, 2011
Anemia management update: an international expert forum on blood transfusion and ESA use. Foreword.
June 30, 2011